Quarterly report pursuant to Section 13 or 15(d)

REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS - Disaggregation of net revenues (Details)

v3.22.2.2
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS - Disaggregation of net revenues (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues $ 16,043 $ 19,610 $ 55,074 $ 45,617
Qbrexza        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 6,265 6,636 19,752 11,204
Accutane        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 4,121 3,531 14,228 5,672
Amzeeq        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 1,161   5,892  
Targadox        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 1,168 5,184 6,558 18,110
Ximino        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 1,773 2,864 3,775 6,277
Zilxi        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues 554   1,851  
Exelderm        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues $ 1,001 1,366 $ 3,018 4,319
Other branded revenue        
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS        
Product revenues   $ 29   $ 35